Type 1 Diabetes in Focus: Optimizing Outcomes with Early Intervention : Episode 1

Type 1 Diabetes: Understanding Disease Progression and Beta Cell Function

March 28, 2025

Opinion

Video

A panelist discusses how type 1 diabetes (T1D) is a complex autoimmune disease characterized by progressive beta cell destruction that advances through distinct stages, with genetic predisposition, environmental triggers and the presence of specific autoantibodies serving as key risk factors and diagnostic markers.

Now Viewing

EP: 1.Type 1 Diabetes: Understanding Disease Progression and Beta Cell Function

EP: 2.C-Peptide and Early Type 1 Diabetes Detection

EP: 3.Advancing Early Detection: Autoimmune Screening in Type 1 Diabetes

EP: 4.Misdiagnosis of Type 1 Diabetes in Adults: Prevalence, Causes and Consequences

EP: 5.Preserving Beta Cell Function in T1D: Current Strategies and Emerging Therapies

EP: 6.Final Thoughts on Type 1 Diabetes: Innovations, Challenges and the Road Ahead

EP: 7.Type 1 Diabetes in Focus: Optimizing With Early Interventions | Written Recap

Video content above is prompted by the following:

How common is T1D? What are the common risk factors associated with the development of T1D?
Discuss the autoimmune nature and disease progression of T1D. What is known about the stages of T1D, particularly in relation to beta cell function?
How does the autoimmune nature of T1D influence the progression of the disease, and what key markers or tests can help us identify where a patient is in the different stages of T1D?

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!